Literature DB >> 1976319

Effects of various direct or indirect dopamine agonists on the latency of the acoustic startle response in rats.

B Naudin1, S Canu, J Costentin.   

Abstract

The effects of dopamine agonists were investigated on the latency of the acoustic startle response in male Wistar rats. Four indirect dopamine agonist were tested: GBR 12783 (5-20 mg/kg), BTCP (5-20 mg/kg), dexamphetamine (3-6 mg/kg) and L-DOPA 100 mg/kg associated with benserazide 25 mg/kg; they induced an increase in startle latency. Apomorphine at a dose (50 micrograms/kg) known to decrease dopaminergic transmissions, was ineffective on the startle response. On the contrary, at 0.6 or 2 mg/kg, apomorphine induced an increase in the startle latency. A similar effect was observed with bromocriptine at 10 mg/kg from the 10th min up to at least the 9th hour after treatment. The specific agonist of D2 receptors Ru 24926 (0.45 mg/kg) enhanced the startle latency as well as the specific agonist of D1 receptors SKF 38393 (10 mg/kg). The association of these drugs resulted in an apparent additivity of their individual effects. The effect of apomorphine (0.6 mg/kg) was only partially reduced by a high dose of the specific D2 antagonist amisulpride (80 mg/kg) and more clearly antagonized by the specific D1 antagonist SCH 23390 (50 micrograms/kg). It is concluded that D2 and D1 receptors contribute to the increase in startle latency elicited by direct or indirect dopamine agonists.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1976319     DOI: 10.1007/bf01244833

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  23 in total

Review 1.  Multiple receptors for dopamine.

Authors:  J W Kebabian; D B Calne
Journal:  Nature       Date:  1979-01-11       Impact factor: 49.962

2.  Dopamine receptors in the central thermoregulatory pathways of the rat.

Authors:  B Cox; R Kerwin; T F Lee
Journal:  J Physiol       Date:  1978-09       Impact factor: 5.182

3.  The discriminant dopamine antagonist property of benzamides is observed at various times after their systemic or intracerebroventricular administration.

Authors:  P Protais; C Hermier; J Costentin
Journal:  Neuropharmacology       Date:  1985-09       Impact factor: 5.250

4.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

Authors:  M Vasse; P Protais; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

5.  Effects of apomorphine and haloperidol on the acoustic startle response in rats.

Authors:  M Davis; G K Aghajanian
Journal:  Psychopharmacology (Berl)       Date:  1976-06-23       Impact factor: 4.530

6.  Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.

Authors:  R Longoni; L Spina; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-02-10       Impact factor: 4.432

7.  Effects of 8-OH-DPAT, lisuride and some ergot-related compounds on the acoustic startle response in the rat.

Authors:  L Svensson
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

8.  SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

Authors:  L C Iorio; A Barnett; F H Leitz; V P Houser; C A Korduba
Journal:  J Pharmacol Exp Ther       Date:  1983-08       Impact factor: 4.030

9.  Hyperbaric effects on sensorimotor reactivity studied with acoustic startle in the rat.

Authors:  J M David; J J Risso; M Weiss; F Brue; J Pellet
Journal:  Physiol Behav       Date:  1988

10.  The central effects of a novel dopamine agonist.

Authors:  P E Setler; H M Sarau; C L Zirkle; H L Saunders
Journal:  Eur J Pharmacol       Date:  1978-08-15       Impact factor: 4.432

View more
  8 in total

1.  Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.

Authors:  Wendy Hasenkamp; Michael P Epstein; Amanda Green; Lisette Wilcox; William Boshoven; Barbara Lewison; Erica Duncan
Journal:  Psychiatry Res       Date:  2010-05-16       Impact factor: 3.222

2.  Effects of single and repeated exposure to apomorphine on the acoustic startle reflex and its inhibition by a visual prepulse.

Authors:  M K Taylor; J R Ison; S B Schwarzkopf
Journal:  Psychopharmacology (Berl)       Date:  1995-07       Impact factor: 4.530

3.  Toxoplasma gondii exposure affects neural processing speed as measured by acoustic startle latency in schizophrenia and controls.

Authors:  Bradley D Pearce; Sydney Hubbard; Hilda N Rivera; Patricia P Wilkins; Marylynn C Fisch; Myfanwy H Hopkins; Wendy Hasenkamp; Robin Gross; Nancy Bliwise; Jeffrey L Jones; Erica Duncan
Journal:  Schizophr Res       Date:  2013-08-13       Impact factor: 4.939

4.  D1 and D2 dopamine receptor antagonists reverse prepulse inhibition deficits in an animal model of schizophrenia.

Authors:  D C Hoffman; H Donovan
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

5.  The auditory startle response in post-traumatic stress disorder.

Authors:  S E Siegelaar; M Olff; L J Bour; D Veelo; A H Zwinderman; G van Bruggen; G J de Vries; S Raabe; C Cupido; J H T M Koelman; M A J Tijssen
Journal:  Exp Brain Res       Date:  2006-03-09       Impact factor: 1.972

6.  Prepulse inhibition of the acoustic startle reflex using visual and auditory prepulses: disruption by apomorphine.

Authors:  S Campeau; M Davis
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

7.  Toxoplasma gondii Effects on the Relationship of Kynurenine Pathway Metabolites to Acoustic Startle Latency in Schizophrenia vs. Control Subjects.

Authors:  Bradley D Pearce; Nicholas Massa; David R Goldsmith; Zeal H Gandhi; Allison Hankus; Alaaeddin Alrohaibani; Neha Goel; Bruce Cuthbert; Molly Fargotstein; Dana Boyd Barr; Parinya Panuwet; Victoria M Brown; Erica Duncan
Journal:  Front Psychiatry       Date:  2020-11-20       Impact factor: 4.157

8.  Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm.

Authors:  Kristin S Cadenhead; Erica Duncan; Jean Addington; Carrie Bearden; Tyrone D Cannon; Barbara A Cornblatt; Dan Mathalon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming Tsuang; Elaine F Walker; Scott W Woods; Peter Bauchman; Ayse Belger; Ricardo E Carrión; Franc Donkers; Jason Johannesen; Gregory Light; Margaret Niznikiewicz; Jason Nunag; Brian Roach
Journal:  Front Psychiatry       Date:  2020-08-25       Impact factor: 4.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.